RALEIGH, N.C., May 3, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) today announced the issuance of nine patents in the United States, Europe and other foreign jurisdictions relating to its development pipeline of compounds to treat diabetes and associated conditions including obesity, cardiovascular disease, Syndrome X; and compounds to treat neuropathic pain. The World Health Organization estimates that more than 220 million people worldwide struggle with diabetes. The global cost of diabetes care exceeds $41 Billion annually.
